This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Getting a community dermatologist's perspective on plaque psoriasis non-steroid topical treatments including Roivant's VTAMA (tapinarof) and Arcutis' Zoryve (roflumilast)
Ticker(s): ROIV, ARQT, INCYWho's the expert?
Institution: Brinton Lake Dermatology
- Board-certified dermatologist who specializes in medical dermatology for all ages and conditions, including acne, rosacea, eczema, psoriasis and skin cancer.
- Manages approximately 300 psoriasis patients.
- Specializes in medical dermatology for all ages and conditions, including acne, rosacea, eczema, psoriasis and skin cancer and offers the most up-to-date, research-supported treatments.
Interview GoalThe purpose of this call is to better understand the plaque psoriasis treatment landscape and prescribing patterns of Zoryve and Vtama. If time allows we will also discuss Opzelura for the treatment of vitiligo and atopic dermatitis.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
